These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11182060)

  • 1. Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study.
    Bretti S; Manzin E; Celano A; Ritorto G; Loddo C; Berruti A
    Oncol Rep; 2001; 8(2):381-5. PubMed ID: 11182060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
    Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II study.
    Cremonesi M; Mandalà M; Cazzaniga M; Rezzani C; Gambera M; Barni S
    Oncology; 2003; 64(2):97-101. PubMed ID: 12566905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.
    Masters GA; Hahn EA; Shevrin DH; Kies MS
    Lung Cancer; 2003 Feb; 39(2):221-6. PubMed ID: 12581577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas.
    Alici S; Coskun U; Alkis N; Sevinc A; Dane F; Gumus M; Ozkan M; Kaya AO; Celenkoglu G; Buyukberber S; Altunbas M; Benekli M;
    Asian Pac J Cancer Prev; 2009; 10(6):1051-5. PubMed ID: 20192582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.
    Horvath L; Boyer M; Clarke S; Beale P; Beith J; Underhill C; Stockler M; Bishop J
    Lung Cancer; 2001 May; 32(2):173-8. PubMed ID: 11325488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II study.
    O'Brien ME; Szczesna A; Karnicka H; Zatloukal P; Eisen T; Hartmann W; Kasan P; Longerey B; Lefresne F
    Ann Oncol; 2004 Jun; 15(6):921-7. PubMed ID: 15151949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials.
    Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Harpidou A; Kalbakis K; Rapti A; Androulakis N; Sarra E; Georgoulias V; Papadakis E
    Oncology; 2001; 60(3):235-41. PubMed ID: 11340375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
    Hoffman PC; Cohen EE; Masters GA; Haraf DJ; Mauer AM; Rudin CM; Krauss SA; Huo D; Vokes EE
    Lung Cancer; 2002 Oct; 38(1):65-71. PubMed ID: 12367795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinoma.
    Hejna M; Kornek GV; Raderer M; Marosi L; Schneeweiss B; Greul R; Weinländer G; Valencak J; Huber H; Scheithauer W
    Oncology; 1998; 55(6):538-42. PubMed ID: 9778620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
    Crawford J; O'Rourke MA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.
    Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Kalbakis K; Rapti A; Androulakis N; Georgoulias V; Papadakis E
    Lung Cancer; 2001 Dec; 34 Suppl 4():S77-80. PubMed ID: 11742708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
    Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
    Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.
    von Plessen C; Bergman B; Andresen O; Bremnes RM; Sundstrom S; Gilleryd M; Stephens R; Vilsvik J; Aasebo U; Sorenson S
    Br J Cancer; 2006 Oct; 95(8):966-73. PubMed ID: 17047644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerologie Study 9902.
    LeCaer H; Delhoume JY; Thomas PA; Berard H; Paillotin D; Barriere JR; Gimenez C; Vergnenegre A; Muller P; Auquier P; Perol M
    Clin Lung Cancer; 2005 Sep; 7(2):114-20. PubMed ID: 16179098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer.
    Takatani H; Nakamura Y; Nagashima S; Soda H; Kinoshita A; Fukuda M; Fukuda M; Soejima Y; Kasai T; Nakatomi K; Iida T; Oka M; Tsukamoto K; Kohno S
    Clin Lung Cancer; 2012 Sep; 13(5):347-51. PubMed ID: 22264660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin and vinorelbine in advanced non-small cell lung cancer: a phase I/II study.
    Masters G
    Oncologist; 2001; 6 Suppl 1():12-5. PubMed ID: 11181999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
    Comella P; Frasci G; De Cataldis G; Panza N; Cioffi R; Curcio C; Belli M; Bianco A; Ianniello G; Maiorino L; Della Vittoria M; Perchard J; Comella G
    Br J Cancer; 1996 Dec; 74(11):1805-11. PubMed ID: 8956797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study.
    Igishi T; Shigeoka Y; Yasuda K; Suyama H; Katayama S; Sugitani A; Matsumoto S; Yamamoto M; Ueda Y; Takeda K; Sumikawa T; Sako T; Kodani M; Hitsuda Y; Shimizu E
    J Thorac Oncol; 2009 Mar; 4(3):376-82. PubMed ID: 19190514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.